Document is current
Any future updates will be listed below
-
Authors
Holzwarth, Sarah
Saadat, Kimiya
Jorczyk, Maximilian
Dreßen, Svenja
Kotsias-Konopelska, Sarah
Schlegtendal, Anne
Maier, Christoph
Schmitt, Jochen
Paul, Kevin
Pagel, Julia
Muntau, Ania C.
Berner, Reinhard
Brinkmann, Folke
Toepfner, Nicole
-
Funding
Funding for this research was provided by:
Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden
- License Information
-
More Information
Article History
Received: 18 August 2024
Accepted: 27 October 2024
First Online: 11 November 2024
Declarations
:
: Prof. Schmitt reports institutional grants for investigator-initiated research from the German Federal Joint Committee, German Ministry of Health, German Ministry of Research, European Union, German Federal State of Saxony, Novartis, Sanofi, ALK, and Pfizer. He participated in advisory board meetings as a paid consultant for Sanofi, Lilly, and ALK. Prof. Schmitt serves the German Ministry of Health as a member of the German National Council for Health and Care.
: The other authors have no conflicts of interest relevant to this article to disclose.
